SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-104041
Filing Date
2017-03-30
Accepted
2017-03-30 16:05:56
Documents
3
Period of Report
2017-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d339710d8k.htm 8-K 13699
2 EX-5.1 d339710dex51.htm EX-5.1 7858
3 EX-10.1 d339710dex101.htm EX-10.1 213000
  Complete submission text file 0001193125-17-104041.txt   235704
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33415 | Film No.: 17725701
SIC: 2834 Pharmaceutical Preparations